Seqens Seqens

X

CAS 16013-85-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 16013-85-7
Also known as: 16013-85-7, Pyridine, 2,6-dichloro-3-nitro-, 2,6-dichloro-3-nitro-pyridine, 3-nitro-2,6-dichloropyridine, Mfcd00006234, Kh7f529l8w
Molecular Formula
C5H2Cl2N2O2
Molecular Weight
192.98  g/mol
InChI Key
SHCWQWRTKPNTEM-UHFFFAOYSA-N
FDA UNII
KH7F529L8W

1 2D Structure

CAS 16013-85-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,6-dichloro-3-nitropyridine
2.1.2 InChI
InChI=1S/C5H2Cl2N2O2/c6-4-2-1-3(9(10)11)5(7)8-4/h1-2H
2.1.3 InChI Key
SHCWQWRTKPNTEM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=NC(=C1[N+](=O)[O-])Cl)Cl
2.2 Other Identifiers
2.2.1 UNII
KH7F529L8W
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 16013-85-7

2. Pyridine, 2,6-dichloro-3-nitro-

3. 2,6-dichloro-3-nitro-pyridine

4. 3-nitro-2,6-dichloropyridine

5. Mfcd00006234

6. Kh7f529l8w

7. 2,6-dichloro-3-nitro Pyridine

8. Einecs 240-151-1

9. Cholest-4-ene, 3-chloro-, (3

10. A)-

11. 2,6-dichloronitropyridine

12. Dichloronitropyridine

13. Unii-kh7f529l8w

14. Schembl56616

15. 2,6-dichioro 3-nitropyridine

16. 2,6-dichloro 3-nitropyridine

17. 2,6-dichloro-5-nitropyridine

18. Dtxsid10166803

19. Zinc967353

20. Act01414

21. 2,6-dichloro-3-nitropyridine Tech.

22. Stk801264

23. 2,6-bis(chloranyl)-3-nitro-pyridine

24. Akos005255252

25. Ac-2768

26. Cs-w001992

27. Pb28956

28. Ps-3147

29. Cholest-4-ene,3-chloro-,(3a)-(9ci)

30. Bp-10097

31. Sy002863

32. Db-005147

33. Am20070294

34. D2761

35. Ft-0610569

36. Ft-0651285

37. 2,6-dichloro-3-nitropyridine 13901-10-5

38. En300-38973

39. 13d857

40. A807471

41. Ac-907/30002032

42. W-107981

43. 2,6-dichloro-3-nitropyridine, Technical Grade, 92%

44. F0001-0573

2.4 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 192.98 g/mol
Molecular Formula C5H2Cl2N2O2
XLogP32.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass191.9493327 g/mol
Monoisotopic Mass191.9493327 g/mol
Topological Polar Surface Area58.7 Ų
Heavy Atom Count11
Formal Charge0
Complexity161
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
16013-85-7
Flupirtine
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and interme...
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.
Aptra Synthesis

Cophex 2024

Not Confirmed

envelop Contact Supplier
Flag China
Digital Content Digital Content
URL Supplier Web Content
16013-85-7
Hunan Huateng Pharmaceutical Co., Ltd. is a research-based manufacturer and supplier of combinatorial bui...
Hunan Huateng Pharmaceutical Co., Ltd. is a research-based manufacturer and supplier of combinatorial building blocks, organics and fine chemicals, with 5000m2 laboratory and over 100 experienced chemists. Huateng is dedicated to bring high quality and cost effective chemical products and services to our clients. Our versatile chemical synthesis expertise and manufacturing capability prepare us to produce a variety of known, novel or even hard-to-find chemicals from kg to ton scale.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY